Africure Pharmaceuticals Ltd 2024 Interim Results For The First Quarter

Africure Pharmaceuticals Ltd (AFRP.mu) Q12024 Interim Report

By Published On: September 5, 2023TYPE: Interim ReportsYear: 2024Period: Q1Country: MauritiusSector: Pharmaceuticals

Africure Pharmaceuticals Ltd (AFRP.mu) listed on the Stock Exchange of Mauritius under the Pharmaceuticals sector has released its 2024 interim results for the first quarter.

For more information about Africure Pharmaceuticals Ltd (AFRP.mu) reports, abridged reports, interim earnings results and earnings presentations visit the Africure Pharmaceuticals Ltd (AFRP.mu) company page on AfricanFinancials.

Africure Pharmaceuticals Ltd 2024 interim results for the first quarter

Company Profile

Africure Pharmaceuticals Ltd is a manufacturer and distributor of high quality essential medication in Africa. It was incorporated on 17 March 2017 and holds a Global Business Licence issued by the Financial Services Commission. The principal activity of the Company is investment holding, trading & procurement of pharmaceutical products. Africure Pharmaceuticals Ltd is listed on the Stock Exchange of Mauritius